Suppr超能文献

[F]氟代脱氧葡萄糖代谢肿瘤体积作为神经内分泌肿瘤的预后标志物:一项多中心研究。

[F]FDG Metabolic Tumor Volume as a Prognostic Marker in Neuroendocrine Neoplasm: A Multicenter Study.

作者信息

Chan David L, Hayes Aimee, Karfis Ioannis, Conner Alice, Mileva Magdalena, Bernard Elizabeth, Navalkissoor Shaunak, Gnanasekaran Gopinath, Clarke Stephen J, Roach Paul J, Flamen Patrick, Caplin Martyn E, Pavlakis Nick, Toumpanakis Christos, Bailey Dale L

机构信息

Medical Oncology Department, ENETS Centre of Excellence, Royal North Shore Hospital, Sydney, New South Wales, Australia;

Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.

出版信息

J Nucl Med. 2025 Jul 1;66(7):1012-1017. doi: 10.2967/jnumed.124.269031.

Abstract

[F]FDG PET/CT avidity predicts higher-grade disease and worse prognosis in patients with metastatic neuroendocrine neoplasm. However, there is less evidence regarding the role of [F]FDG-avid tumor volume in predicting prognosis. We planned to determine whether metabolic tumor volume (MTV) on [F]FDG PET/CT predicts prognosis in patients with advanced gastroenteropancreatic neuroendocrine neoplasm (GEPNEN). A multicenter retrospective study was performed on patients with advanced GEPNEN who underwent [F]FDG PET/CT in a previously established cohort. Images were acquired across 3 centers using harmonized protocols and were contoured and verified at a flat SUV threshold of 4 using a semiautomated software workflow. The primary endpoint was overall survival. Patients were dichotomized into high- and low-MTV groups by the median value, with the overall survival of the 2 resulting cohorts compared by log-rank tests and multivariate analyses. In total, 231 patients were included (49% male; median age, 60 y). In 45% of cases the primary was the pancreas, in 42% the small bowel, and in 13% another location. Regarding World Health Organization 2019 grade, 23% were grade 1, 52% grade 2, 21% grade 3, and 4% an unknown grade. The median follow-up was 27 mo (interquartile range, 11-49 mo), and median overall survival was 38.6 mo. Median overall survival was shorter in the high-MTV cohort than in the low-MTV cohort (cut point, 16.5 cm; 23.8 mo vs. not reached; hazard ratio, 2.49; 95% CI, 1.69-3.66; < 0.0001). Median time to treatment failure was also shorter in the high-MTV cohort (11.7 mo vs. 16.9 mo; hazard ratio, 1.52; 95% CI, 1.13-2.06; = 0.005). Increasing histologic grade was associated with higher MTV ( = 0.0006, 1-way ANOVA). Multivariate analysis incorporating age, grade, sex, SUV, and MTV showed that only grade ( = 0.001) and MTV ( < 0.001) were independently prognostic. MTV is a prognostic biomarker in advanced GEPNEN. Reports of [F]FDG PET in GEPNEN may benefit from comments on MTV in addition to the degree of [F]FDG avidity.

摘要

[F]氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG PET/CT)的摄取情况可预测转移性神经内分泌肿瘤患者的疾病分级较高及预后较差。然而,关于[F]氟代脱氧葡萄糖摄取性肿瘤体积在预测预后方面的作用,证据较少。我们计划确定[F]FDG PET/CT上的代谢肿瘤体积(MTV)是否可预测晚期胃肠胰神经内分泌肿瘤(GEPNEN)患者的预后。对先前建立的队列中接受[F]FDG PET/CT检查的晚期GEPNEN患者进行了一项多中心回顾性研究。在3个中心使用统一方案采集图像,并使用半自动软件工作流程在SUV阈值为4的平面上进行轮廓勾画和验证。主要终点是总生存期。通过中位数将患者分为高MTV组和低MTV组,通过对数秩检验和多变量分析比较这两个队列的总生存期。总共纳入了231例患者(49%为男性;中位年龄60岁)。45%的病例原发部位为胰腺,42%为小肠,13%为其他部位。关于世界卫生组织2019年分级,23%为1级,52%为2级,21%为3级,4%分级未知。中位随访时间为27个月(四分位间距为11 - 49个月),中位总生存期为38.6个月。高MTV队列的中位总生存期短于低MTV队列(切点为16.5 cm;23.8个月对未达到;风险比为2.49;95%置信区间为1.69 - 3.66;P<0.0001)。高MTV队列的中位治疗失败时间也较短(11.7个月对16.9个月;风险比为1.52;95%置信区间为1.13 - 2.06;P = 0.005)。组织学分级增加与MTV升高相关(P = 0.0006,单因素方差分析)。纳入年龄、分级、性别、SUV和MTV的多变量分析显示,只有分级(P = 0.001)和MTV(P<0.001)具有独立的预后价值。MTV是晚期GEPNEN的一种预后生物标志物。GEPNEN的[F]FDG PET报告除了[F]FDG摄取程度外,可能还应提及MTV。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验